The National Aids Strategy

This document is a companion to the National HIV/AIDS Strategy for the United States. It presents the Administration's plan for measuring progress toward meeting the Strategy's goals, and includes immediate and short-term Federal actions (those that can be achieved in calendar years 2010 and 2011) that will move the Nation toward improving its response to HIV/AIDS.

The AIDS epidemic in Sub-Saharan Africa continues to affect all facets of life throughout the subcontinent. Deaths related to AIDS have driven down the life expectancy rate of residents in Zambia, Kenya, and Uganda with far-reaching implications. This book details the current state of the AIDS epidemic in Africa and what is known about the behaviors that contribute to the transmission of the HIV infection. It lays out what research is needed and what is necessary to design more effective prevention programs.

President Obama committed to developing a National HIV/AIDS Strategy with three primary goals: reducing the number of people who become infected with HIV, increasing access to care and optimizing health outcomes for people living with HIV, and reducing HIV-related health disparities. The Strategy is intended to be a concise plan that will identify a set of priorities and strategic action steps tied to measurable outcomes

The Nation's first comprehensive National HIV/AIDS Strategy for the United States (Strategy) was released in 2010, and in the subsequent five years, people and organizations have joined together around its vision and goals. The Strategy has changed the way the American people talk about HIV, prioritize and organize prevention and care services locally, and deliver clinical and non-clinical services that support people living with HIV to remain engaged in care, and has helped achieve the following: Implementation of the Afoordable Care Act; Groundbreaking work by the National Institutes of Health; Introduction of PrEP (pre-exposure prophylaxis); Vital work by the Centers for Disease Control and Prevention; Critical funding increases for the AIDS Drug Assistance Progra (ADAP) of the HRSA; and others.